BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2257863)

  • 1. The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon.
    Mönig H; Böhm M; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1990; 39(3):261-5. PubMed ID: 2257863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Probenecid affects liver metabolism].
    Bammel A; Mönig H; Zurborn KH; Ohnhaus EE; Kirch W
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1831-4. PubMed ID: 2609138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.
    Mönig H; Baese C; Heidemann HT; Ohnhaus EE; Schulte HM
    Br J Clin Pharmacol; 1990 Jul; 30(1):115-8. PubMed ID: 2390422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of co-administered organic acids on the kinetics and dynamics of frusemide.
    Sommers DK; Meyer EC; Moncrieff J
    Br J Clin Pharmacol; 1991 Oct; 32(4):489-93. PubMed ID: 1958444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics.
    Masche UP; Rentsch KM; von Felten A; Meier PJ; Fattinger KE
    Eur J Clin Pharmacol; 1999 Jan; 54(11):857-64. PubMed ID: 10027661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of phenprocoumon.
    Haustein KO; Hüller G
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):192-7. PubMed ID: 8032579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    Br J Clin Pharmacol; 1995 Jun; 39(6):692-5. PubMed ID: 7654491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
    J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon.
    Russmann S; Dilger K; Trenk D; Nagyivanyi P; Jähnchen E
    Arzneimittelforschung; 2001 Nov; 51(11):891-5. PubMed ID: 11765590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
    Kitteringham NR; Büstgens L; Brundert E; Mineshita S; Ohnhaus EE
    Eur J Clin Pharmacol; 1984; 26(1):65-70. PubMed ID: 6714293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography-mass spectrometry after solid-phase extraction.
    Ufer M; Kammerer B; Kirchheiner J; Rane A; Svensson JO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):217-26. PubMed ID: 15315768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of flupirtine coadministration on phenprocoumon plasma concentrations and prothrombin time.
    Harder S; Thürmann P; Hermann R; Weller S; Mayer M
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):577-81. PubMed ID: 7874369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment basis for anticoagulants in horses].
    Sinn D; Wintzer HJ
    Tierarztl Prax; 1990 Oct; 18(5):507-11. PubMed ID: 2264055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction profile of carvedilol: investigations with digitoxin and phenprocoumon.
    Caspary S; Merz PG; Brei R; Harder S
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):537-8. PubMed ID: 1490823
    [No Abstract]   [Full Text] [Related]  

  • 17. Concentrations of phenprocoumon in serum and serum water determined by high-performance liquid chromatography in patients on oral anticoagulant therapy.
    Petersen D; Barthels M; Schumann G; Büttner J
    Haemostasis; 1993; 23(2):83-90. PubMed ID: 8365690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers.
    Stass H; Sachse R
    Clin Pharmacokinet; 2001; 40 Suppl 1():71-6. PubMed ID: 11352445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of probenecid on furosemide response.
    Brater DC
    Clin Pharmacol Ther; 1978 Nov; 24(5):548-54. PubMed ID: 699479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of a pharmacokinetic interaction between carvedilol and digitoxin or phenprocoumon.
    Harder S; Brei R; Caspary S; Merz PG
    Eur J Clin Pharmacol; 1993; 44(6):583-6. PubMed ID: 8405017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.